JPMorgan Chase to Limit Number of AMJ Shares

With an estimated $70 trillion in global OTC derivatives exposure, JPMorgan is cutting back its swap exposure by capping the shares in its ETN program More 

The Troubling Evolution of Exchange-Traded ‘Products’

The exchange-traded products category has morphed in ways that can be extremely risky -- and worse, they can mislead uninformed investors into very unwise purchases. More 

ETN Sponsors’ ‘Double Dip’ Hurts Shareholders

Credit Suisse and Barclays have been double-dipping by lending out ETN shares to traders that short them, while simultaneously collecting fees from investors. More 

Volatility ETN Rears Its Ugly Head

The TVIX's recent rapid descent provides a valuable lesson about the dangers of ETNs and other volatility-tracking products. More 

Volatility Oddities Could Impact Broad Market

Interest in volatility products continues to grow despite low levels in the VIX. More 

The 7 Priciest ETFs (and What You Get)

These ETFs aim to triple your money, allow you to bet on fear and more ... but for a price. They also have the highest expense ratios out there today. More 

VIX and Other Indicators Signal a Stock Slide

With the S&P 500 in seriously overbought territory, a correction looks to be near. Here are 3 ETFs that let you play the VIX. More